Alzheimer’s Drug Lecanemab Receives Fast-Track Approval Due to Safety Concerns | CNN
CNN — The U.S. Food and Drug Administration on Friday granted accelerated approval to the Alzheimer’s disease drug lecanemab, one of the first experimental dementia drugs to appear to slow the progression of cognitive decline. “Alzheimer’s disease immeasurably cripples the lives of those who suffer from it and has devastating effects on their loved ones,” …
Alzheimer’s Drug Lecanemab Receives Fast-Track Approval Due to Safety Concerns | CNN Read More »
